Serum testosterone levels significantly correlate with nocturia in men aged 40-79 years

Urology

Volumn 78, Issue 3, 2011, Pages 631-635

  Liao, Chun Hou ^a,b,c   Chiang, Han Sun ^a,b   Yu, Hong Jeng ^c  

^a CARDINAL TIEN HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; ESTRADIOL; TESTOSTERONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; ESTRADIOL BLOOD LEVEL; HUMAN; HYPERTENSION; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; NOCTURIA; PRIORITY JOURNAL; PROSTATE; PROSTATE VOLUME; QUESTIONNAIRE; TESTOSTERONE BLOOD LEVEL; TRANSRECTAL ULTRASONOGRAPHY; URETHRA; UROLOGIC EXAMINATION;

ADULT; AGED; DIHYDROTESTOSTERONE; ESTRADIOL; HUMANS; MALE; MIDDLE AGED; NOCTURIA; PROSTATE; PROSTATIC HYPERPLASIA; TESTOSTERONE; URINATION DISORDERS;

EID: 80052311651     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2011.05.033     Document Type: Article

References (26)

1. P. Abrams, L. Cardozo, M. Fall Standardisation Sub-committee of the International Continence Society The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society Neurourol Urodyn 21 2002 167 178 (Pubitemid 34195211)
2. C.R. Chapple, A.J. Wein, and P. Abrams Lower urinary tract symptoms revisited: a broader clinical perspective Eur Urol 54 2008 563 569
3. C. Carson III, and R. Rittmaster The role of dihydrotestosterone in benign prostatic hyperplasia Urology 61 2003 2 7 (Pubitemid 36349123)
4. G. Andriole, N. Bruchovsky, and L.W. Chung Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia J Urol 172 2004 1399 1403 (Pubitemid 39249729)
5. G. Schatzl, C. Brössner, and S. Schmid Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function: the Prostate Study Group of the Austrian Society of Urology Urology 55 2000 397 402 (Pubitemid 30110593)
6. C.C. Liu, S.P. Huang, and W.M. Li Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men Urology 70 2007 677 680
7. Y. Miwa, T. Kaneda, and O. Yokoyama Association between lower urinary tract symptoms and serum levels of sex hormones in men Urology 72 2008 552 555
8. S. Rohrmann, W.G. Nelson, and N. Rifai Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III) Urology 69 2007 708 713 (Pubitemid 46574931)
9. H.J. Litman, S. Bhasin, and M.P. O'Leary An investigation of the relationship between sex-steroid levels and urological symptoms: results from the Boston Area Community Health survey BJU Int 100 2007 321 326 (Pubitemid 47036575)
10. V. Favilla, S. Cimino, and T. Castelli Relationship between lower urinary tract symptoms and serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia BJU Int 106 2010 1700 1703
11. I.H. Chang, S.Y. Oh, and S.C. Kim A possible relationship between testosterone and lower urinary tract symptoms in men J Urol 182 2009 215 220
12. M.D. Trifiro, J.K. Parsons, and K. Palazzi-Churas Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men BJU Int 105 2010 1554 1559
13. C.H. Liao, S.D. Chung, and H.C. Kuo Diagnostic value of International Prostate Symptom Score voiding-to-storage subscore ratio in male lower urinary tract symptoms Int J Clin Pract 65 2011 552 558
14. C.R. Chapple, F. Montorsi, and T.L. Tammela Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe Eur Urol 59 2011 342 352
15. C. Wang, E. Nieschlag, and R. Swerdloff Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations J Androl 30 2009 1 9
16. S. Boongird, N. Shah, and T.D. Nolin Nocturia and aging: diagnosis and treatment Adv Chronic Kidney Dis 17 2010 e27 e40
17. I. Pávó, C. Varga, and M. Szcs Effects of testosterone on the rat renal medullary vasopressin receptor concentration and the antidiuretic response Life Sci 56 1995 1215 1222
18. N.H. Herzberg, E. Goudsmit, and J. Kruisbrink Testosterone treatment restores reduced vasopressin-binding sites in the kidney of the ageing rat J Endocrinol 123 1989 59 63 (Pubitemid 19254933)
19. T.R. Pak, W.C. Chung, and L.R. Hinds Estrogen receptor-beta mediates dihydrotestosterone-induced stimulation of the arginine vasopressin promoter in neuronal cells Endocrinology 148 2007 3371 3382 (Pubitemid 46996994)
20. B.A. Rosenzweig, P.S. Bolina, and L. Birch Location and concentration of estrogen, progesterone, and androgen receptors in the bladder and urethra of the rabbit Neurourol Urodyn 14 1995 87 96
21. A.A. Yassin, A.I. El-Sakka, and F. Saad Lower urinary-tract symptoms and testosterone in elderly men World J Urol 26 2008 359 364
22. J.R. Keast The autonomic nerve supply of male sex organsan important target of circulating androgens Behav Brain Res 105 1999 81 92 (Pubitemid 29447614)
23. T.W. Watkins, and J.R. Keast Androgen-sensitive preganglionic neurons innervate the male rat pelvic ganglion Neuroscience 93 1999 1147 1157 (Pubitemid 29341661)
24. R. Hall, P.L. Andrews, and C.H. Hoyle Effects of testosterone on neuromuscular transmission in rat isolated urinary bladder Eur J Pharmacol 449 2002 301 309
25. S. Filippi, A. Morelli, and P. Sandner Characterization and functional role of androgen-dependent PDE5 activity in the bladder Endocrinology 148 2007 1019 1029
26. P.J. Smet, J. Jonavicius, and V.R. Marshall Distribution of nitric oxide synthase-immunoreactive nerves and identification of the cellular targets of nitric oxide in guinea-pig and human urinary bladder by cGMP immunohistochemistry Neuroscience 71 1996 337 348 (Pubitemid 26067004)